AtaiBeckley Inc.
BPL-003
treatment-resistant depression
Countdown
998days
Phase 3 readout · ~ Mar 31, 2029 estimated
What's at stake
Phase 3 trial results for BPL-003 in treatment-resistant depression are due ~ Mar 31, 2029. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“Early 2029: BPL-003 Phase 3 topline readouts”